Pharmafile Logo
Pharmafocus logo
Advanced Search

Overdose deaths lead to co-proxamol withdrawal

February 1, 2005
Sales and Marketing

Co-proxamol, a commonly prescribed painkiller, will be withdrawn from use in the UK because of continued deaths from overdose.The drug …

News

Changing the headlines

February 1, 2005
Medical Communications

'You kill people, don't you?' someone said to me when I mentioned my job was in pharma market research. Statements …

Feature

NHS Trust – can pharma win it?

February 1, 2005

Sometimes pharma companies could be forgiven for thinking they are in a catch-22 situation. On the one hand local NHS …

Feature

Open up to expert patients

January 28, 2005
Medical Communications

The pharma industry has a crucial role to play in the successful roll-out of the Expert Patients Programme (EPP) and …

Feature

Humira tipped for blockbuster status in 2005

January 25, 2005
Sales and Marketing

Abbott Laboratories has raised its sales expectations for rheumatoid arthritis treatment Humira and now expects the product's sales to reach …

News

Lipitor breaks $10 billion annual sales mark

January 21, 2005
Sales and Marketing

Pfizer's blockbuster statin Lipitor scaled new sales heights in 2004, becoming the first pharma product to make more than $10 …

News

MHRA admits to shortcomings

January 21, 2005
Sales and Marketing

The MHRA has admitted that it has "suffered from not being professional enough" as it endeavoured to restore its reputation …

News

UK industry seizes initiative to head off call for new laws

January 21, 2005

The UK pharmaceutical industry has put forward new proposals to reform itself and its relations with regulators and patients in …

News

Plavix leads the way in UK sales growth

January 20, 2005
Sales and Marketing

News

AstraZeneca looks to oncology pipeline after failure of Iressa

January 20, 2005
Sales and Marketing

AstraZeneca has withdrawn its marketing application for its lung cancer drug Iressa in the European Union following the release of …

News

FDA blocks self-diagnosis over-the-counter statin Mevacor

January 20, 2005
Medical Communications

Merck and Johnson & Johnson's application to sell the statin Mevacor (lovastatin) has failed to gain approval from an FDA …

News

Pfizer survey shows UK patients want greater information

January 20, 2005
Medical Communications

Nearly half of UK patients with long-term conditions don't think they have enough information about their disease and that this …

News

Text messages and e-mails to help spread health message

January 20, 2005
Medical Communications

Patients with long-term conditions are to be provided with more information and improved services to encourage them to take better …

News

Breakthrough cancer drug Avastin approved

January 20, 2005
Sales and Marketing

Roche’s new colon cancer treatment Avastin has been approved by the European Commission, where it will go on sale at …

News

Lilly takes on BMJ over Prozac claims

January 20, 2005
Sales and Marketing

Eli Lilly has gone on the offensive over allegations that it concealed important safety information on its antidepressant drug Prozac.In …

News

Med comms veteran launches Acumen

January 14, 2005
Medical Communications

Medical communications veteran Brian Palphramand has launched a new agency with the aim of providing a tailor-made medical communications service.Basingstoke-based …

News

Antisoma acquires exciting new anti-cancer drug

January 14, 2005
Research and Development

News

We can work it out

January 13, 2005
Sales and Marketing

Selling pharmaceuticals successfully is really dependent on three factors. You must acquire and demonstrate a high level of disease area …

Feature

Building a body of evidence

January 10, 2005
Sales and Marketing

Feature

Global industry commits to new data openness

January 7, 2005
Sales and Marketing

The global pharmaceutical industry has committed to making available all data relating to all marketed products, in a move designed …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025